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Short Communication
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The human c-myc proto-oncogene is the genomic
homologue of the transforming sequences found in
MC29, an avian retrovirus that can cause
myelocytomatosis, carcinoma, sarcoma and
lymphoma (Graf & Beug, 1978; Enrietto et al.,
1983). Alterations in the structure or expression of
c-myc have been associated with several forms of
neoplasia including avian leukosis virus induced B-
cell lymphoma, rodent plasmacytoma and human
Burkitt's lymphoma, leukaemia, colon carcinoma
and variant small cell lung cancer (Hayward et al.,
1981; Payne et al., 1982; Shen-Ong et al., 1982;
Taub et al., 1982; Collins & Groudine, 1982; Dalla-
Favera et al., 1982; Crews et al., 1982; Little et al.,
1983; Sumegi et al., 1983; Mushinski et al., 1983;
Alitaloetal., 1983;Erismanetal., 1985; Rothbergetal.,
1984). In a study of adenocarcinoma of the colon
and rectum we have shown significantly elevated
expression of c-myc in the majority of tumours,
although no evidence of rearrangement or
amplification of the gene could be demonstrated
(Erisman et al., 1985). In the course of these studies
on unselected tumours we have observed that
elevated expression of the myc gene occurs more
frequently in tumours of the left side (rectum,
sigmoid, and descending colon) than in tumours of
the right side (caecum and ascending colon). We
discuss this finding in view of published reports of
similar asymmetries in site distribution in inherited
forms ofcolon cancer.
Figure 1 shows a dot blot analysis of the myc
RNA level in several colorectal adenocarcinomas
and in samples of nearby uninvolved tissue.
Expression of myc in a sample is designated as
significantly elevated (patients 2,3,4 and 8 in Figure
1) if the myc signal (panel A) is at least 5-fold
elevated compared to normal colonic mucosa. This
is outside of the range of experimental error as
described previously (Rothberg et al., 1984).
Hybridization of an identical dot blot with a
human c-myc probe reveals no consistent difference
between tumour and normal tissue for this
oncogene and demonstrates that all lanes have
roughly equal amounts of hybridizable RNA
(Figure 1, panel B).
Table I shows the site distribution of unselected
tumour samples with and without elevated
expression of c-myc RNA. There is a significant
correlation of elevated myc expression with
carcinoma of the left side. Tumours of the right
side are less likely to contain a significantly elevated
level of myc RNA. Chi square analysis of the data
in which the null hypothesis states that the tumours
from either side form one population with respect
to elevated myc expression is rejected at the
p<0.025 level (using Yates correction). Other
clinical parameters such as Dukes stage and
histological appearance of the tumour, the level of
serum carcinoembryonic antigen, age and sex of the
patient were not significantly different when the
elevated and not-elevated groups were compared
(data not shown).
Published reports on site distribution in the
inherited forms of colon cancer may provide an
explanation for the asymmetry in myc expression
we have found in unselected tumours. Familial
polyposis coli (FPC) is an autosomal dominant trait
characterized by numerous adenomatous polyps
and eventual colon carcinoma usually occurring in
the distal colon (Anderson & Williams, 1985;
Bussey, 1975). Hereditary non-polyposis colorectal
cancer (HNPCC) is also an autosomal dominant
trait, but the tumours appear predominantly on the
right side of the large bowel and are not preceded
by the development ofmultiple polyps (Anderson &
Williams, 1985; Anderson, 1980; Lynch et al.,
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samples shown here were chosen to represent the asymmetry in myc expression seen between left and right
sided carcinoma of the colon. The splenic flexure is the bend between the transverse and descending colon
near the spleen. 'N' indicates normal mucosa which was located a few centimeters away from the tumour
indicated by 'C'. Panel A: Preparation of the dot blot and hybridization with exon 3 of the human c-myc gene
was done as described in Erisman et at. (1985). Panel B: Hybridization with human c-myb was done with a
probe (0.7 kb, BamHI-XbaI) obtained from A. Begue (Leprince et at., 1983) using the same conditions as for
myc. The myb blot was washed several times in 2 x SSC (1 x SSC is 0.15 M sodium chloride, 0.015 M sodium
citrate), 0.1% sodium dodecylsulfate (SDS) at room temperature, then at 330 in 80%/ formamide, 3 x SSC, 0.1%
SDS before exposure at -700 with an intensifying screen. The myc blot was exposed 19h, and the myb blot
was exposed 160h.CLINICAL CORRELATES OF C-MYC EXPRESSION IN COLON CANCER 631
1977). Table I shows site distribution data for
tumours from these diseases. There is a close
similarity in the site distribution of the carcinoma
samples with low myc RNA and the HNPCC
patients (Table I, columns I and III). Likewise,
there is a close correlation of the site distribution in
FPC and the tumours we studied with a
significantly elevated level of myc RNA (Table I,
columns II and IV).
The data shown here support, but do not prove,
the hypothesis that elevated expression of the myc
gene is a marker of a distinct form of colon
carcinoma that is the sporadic version of the
inherited carcinoma of familial polyposis coli. It is
also possible that elevated myc expression is an
essential part of the neoplastic phenotype in this
disease (Erisman et al., 1985). The tumours with
low myc expression would be the sporadic
counterpart of hereditary non-polyposis colorectal
cancer. This hypothesis predicts that FPC tumours
would have significantly elevated myc expression
regardless of site, while HNPCC tumours would
consistently lack elevated myc expression, also
regardless of site. This prediction remains to be
tested.
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Table I Site distribution in colorectal adenocarcinoma: Elevated myc expression
compared with inherited colon cancer syndromes. Percentages at each site are given.
Myc RNA level' Inherited colon cancer
I II III IV
Location not elevatedb elevatedb HNPCCC FPCd
Lefte 5 (42%) 22 (85%) 35% 84%
Rightf 7 (58%) 4 (15%) 65% 16%
Total 12 (100%) 26 (100%) 100% 100%
ac-myc RNA levels were determined by dot blot hybridization as shown in Figure 1
and confirmed by Northern blot analysis in several cases (Erisman, et al., 1985). The
actual number of patients in this unselected study is shown with the percentages in
parenthesis; bNot elevated <5X of normal controls < elevated; cHereditary non-
polyposis colorectal cancer. The data are from 220 patients summarized by Anderson
(1980); dFamilial polyposis coli. The data are from 263 patients studied by Bussey
(1975); eTumours of the left side are located in the rectum, splenic flexure, sigmoid
colon and descending colon; fThe tumours of the right side are in the caecum, hepatic
flexure, ascending colon and transverse colon.
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